By bertrand
🎉Cardiawave has just reached 8,000 followers on LinkedIn! January 29, 2026 🎉 Cardiawave has just reached 8,000 followers on LinkedIn! A heartfelt thank you to each and every member of our community for your trust, interest, and continuous support. Your engagement fuels our mission to bring a breakthrough, non‑invasive ultrasound therapy to patients suffering from … Continued
By bertrand
Congratulations to Prof. Hélène Eltchaninoff on becoming President of the French Society of Cardiology! 🎉 January 22, 2026 We are proud to celebrate the appointment of Prof. Eltchaninoff as the new President of the French Society of Cardiology (@Société Française de Cardiologie). The handover ceremony took place during the JESFC congress in Paris, marking an important … Continued
By bertrand
🔊 New Interview – Inside Cardiawave’s Journey with the EIC Scaling Club January 13, 2026 We are delighted to share our latest interview with the EIC Scaling Club, highlighting Cardiawave’s journey and our mission to transform the treatment of aortic valve disease through fully non-invasive innovation. In this interview, our CEO @Carine Schorochoff discusses:Why non-invasive solutions … Continued
By bertrand
Cardiawave at JESFC 2026! January 8th 2026 Cardiawave is delighted to attend the upcoming Journées Européennes de la Société Française de Cardiologie (JESFC 2026), taking place in Paris from January 14 to 16! We warmly congratulate Prof. @Hélène Eltchaninoff, who will become the new President of the French Society of Cardiology during this annual congress. 📅 Save … Continued
By bertrand
04/12/2025 VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking Cardiawave_PR CE Mark Valvosoft 2025-12-04Download << Press Release
By bertrand
04/12/2025 VALVOSOFT®, le premier traitement non invasif de la Sténose Aortique Sévère symptomatique (sSAS) développé par Cardiawave, obtient le marquage CE Cardiawave_PR CE Mark Valvosoft 2025-12-04_FRDownload << Press Release
By bertrand
📢 Cardiawave’s Valvosoft® to be presented at PCR London Valves 2025! November 6th, 2025 We are pleased to share that Valvosoft®, our non-invasive ultrasound therapy for aortic stenosis, will be featured in two sessions on Sunday, 16 November: 🧠 Innovation/CV Pipeline Session🕒 14:00 – 15:00📍 Room A🎤 Presentation: Aortic Valve Stenosis: New Non-invasive Treatment Options 📊 Valvosoft® … Continued
By bertrand
27/10/2025 Cardiawave renforce son leadership avec la nomination de Jonathan Freeman, Président du CA PR Cardiawave Nomme Jonathan Freeman Président du CA – 27 10 2025Download << Press Release
By bertrand
23/10/2025 Cardiawave Strengthens Leadership with Appointment of Jonathan Freeman as Board Chairman PR Cardiawave Appoints Jonathan Freeman as COB – 23 10 2025Download << Press Release
By bertrand
🎙️ Cardiawave’s presentation at LSI 2025 October 21st, 2025 We are pleased to share the presentation delivered by our CEO, Carine Schorochoff, at LSI 2025, a leading event dedicated to medtech innovation and investment.Her talk highlights Cardiawave’s mission to transform the treatment of aortic stenosis through noninvasive ultrasound therapy — a breakthrough approach in cardiovascular … Continued